Diabetes

Ultrawide field retinal imaging improves telehealth evaluation

(HealthDay)—Implementation of non-mydriatic ultrawide field retinal imaging (UWFI) in a telemedicine program significantly reduces the ungradable rate in evaluation of patients for diabetic retinopathy (DR) and diabetic ...

Ophthalmology

High hsCRP may up risk of macular edema in T1DM

(HealthDay)—For patients with type 1 diabetes mellitus, elevated levels of high-sensitivity C-reactive protein (hsCRP) are associated with an increased risk of clinically significant macular edema (CSME) and with the development ...

Diabetes

Microaneurysm turnover IDs macular edema development

(HealthDay)—Microaneurysm (MA) turnover independently predicts the development of clinically significant macular edema (CSME) in patients with non-proliferative diabetic retinopathy (NPDR), according to a study published ...

Ophthalmology

Long-term ranibizumab beneficial for macular edema

(HealthDay)—Long-term aggressive treatment of patients with macular edema with ranibizumab during a third year correlates with reduced mean foveal thickness (FTH) and improved best-corrected visual acuity (BCVA), according ...

Medications

FDA approves drug to treat diabetic macular edema

The U.S. Food and Drug Administration today announced its approval of Lucentis (ranibizumab injection) for the treatment of diabetic macular edema, or DME, an eye condition in people with diabetes that causes blurred vision, ...

page 6 from 7